Mitigating the impact of COVID-19 on colorectal cancer screening: Organized service screening perspectives from the Asia-Pacific region
Colorectal cancer(CRC) is one of the most prevalent malignancies in the Asia-Pacific region, and many countries in this region have launched population CRC service screening. In this study, CRC screening key indicators, including the FIT(fecal immunochemical test) screening rate (or participation ra...
Uloženo v:
| Vydáno v: | Preventive medicine Ročník 151; s. 106622 |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
Elsevier Inc
01.10.2021
The Author(s). Published by Elsevier Inc |
| Témata: | |
| ISSN: | 0091-7435, 1096-0260, 1096-0260 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Colorectal cancer(CRC) is one of the most prevalent malignancies in the Asia-Pacific region, and many countries in this region have launched population CRC service screening. In this study, CRC screening key indicators, including the FIT(fecal immunochemical test) screening rate (or participation rate) and the rate of undergoing colonoscopy after positive FIT in 2019 and 2020, were surveyed in individual countries in the Asia-Pacific region. The impact of the pandemic on the effectiveness of CRC screening was simulated given different screening rates and colonoscopy rates and assuming the pandemic would persist or remain poorly controlled for a long period of time, using the empirical data from the Taiwanese program and the CRC natural history model.
During the COVID-19 pandemic, most of the programs in this region were affected, but to different extents, which was largely influenced by the severity of the local pandemic. Most of the programs continued screening services in 2020, although a temporary pause occurred in some countries. The modeling study revealed that prolonged pauses of screening led to 6% lower effectiveness in reducing CRC mortality.
Screening organizers should coordinate with health authorities to elaborate on addressing screening backlogs, setting priorities for screening, and applying modern technologies to overcome potential obstacles. Many novel approaches that were developed and applied during the COVID-19 pandemic, such as the risk-stratified approach that takes into account personal CRC risk and the local epidemic status, as well as new digital technologies, are expected to play important roles in CRC screening in the future.
•More than half of global colorectal cancers (CRCs) currently occur in the Asia-Pacific region.•The COVID-19 pandemic has significantly affected CRC screening service globally, but less so in the Asia-Pacific region.•Risk-stratified approach and modern technologies are the key to mitigating the impact of pandemics on CRC screening. |
|---|---|
| AbstractList | Colorectal cancer(CRC) is one of the most prevalent malignancies in the Asia-Pacific region, and many countries in this region have launched population CRC service screening. In this study, CRC screening key indicators, including the FIT(fecal immunochemical test) screening rate (or participation rate) and the rate of undergoing colonoscopy after positive FIT in 2019 and 2020, were surveyed in individual countries in the Asia-Pacific region. The impact of the pandemic on the effectiveness of CRC screening was simulated given different screening rates and colonoscopy rates and assuming the pandemic would persist or remain poorly controlled for a long period of time, using the empirical data from the Taiwanese program and the CRC natural history model. During the COVID-19 pandemic, most of the programs in this region were affected, but to different extents, which was largely influenced by the severity of the local pandemic. Most of the programs continued screening services in 2020, although a temporary pause occurred in some countries. The modeling study revealed that prolonged pauses of screening led to 6% lower effectiveness in reducing CRC mortality. Screening organizers should coordinate with health authorities to elaborate on addressing screening backlogs, setting priorities for screening, and applying modern technologies to overcome potential obstacles. Many novel approaches that were developed and applied during the COVID-19 pandemic, such as the risk-stratified approach that takes into account personal CRC risk and the local epidemic status, as well as new digital technologies, are expected to play important roles in CRC screening in the future.Colorectal cancer(CRC) is one of the most prevalent malignancies in the Asia-Pacific region, and many countries in this region have launched population CRC service screening. In this study, CRC screening key indicators, including the FIT(fecal immunochemical test) screening rate (or participation rate) and the rate of undergoing colonoscopy after positive FIT in 2019 and 2020, were surveyed in individual countries in the Asia-Pacific region. The impact of the pandemic on the effectiveness of CRC screening was simulated given different screening rates and colonoscopy rates and assuming the pandemic would persist or remain poorly controlled for a long period of time, using the empirical data from the Taiwanese program and the CRC natural history model. During the COVID-19 pandemic, most of the programs in this region were affected, but to different extents, which was largely influenced by the severity of the local pandemic. Most of the programs continued screening services in 2020, although a temporary pause occurred in some countries. The modeling study revealed that prolonged pauses of screening led to 6% lower effectiveness in reducing CRC mortality. Screening organizers should coordinate with health authorities to elaborate on addressing screening backlogs, setting priorities for screening, and applying modern technologies to overcome potential obstacles. Many novel approaches that were developed and applied during the COVID-19 pandemic, such as the risk-stratified approach that takes into account personal CRC risk and the local epidemic status, as well as new digital technologies, are expected to play important roles in CRC screening in the future. Colorectal cancer(CRC) is one of the most prevalent malignancies in the Asia-Pacific region, and many countries in this region have launched population CRC service screening. In this study, CRC screening key indicators, including the FIT(fecal immunochemical test) screening rate (or participation rate) and the rate of undergoing colonoscopy after positive FIT in 2019 and 2020, were surveyed in individual countries in the Asia-Pacific region. The impact of the pandemic on the effectiveness of CRC screening was simulated given different screening rates and colonoscopy rates and assuming the pandemic would persist or remain poorly controlled for a long period of time, using the empirical data from the Taiwanese program and the CRC natural history model. During the COVID-19 pandemic, most of the programs in this region were affected, but to different extents, which was largely influenced by the severity of the local pandemic. Most of the programs continued screening services in 2020, although a temporary pause occurred in some countries. The modeling study revealed that prolonged pauses of screening led to 6% lower effectiveness in reducing CRC mortality. Screening organizers should coordinate with health authorities to elaborate on addressing screening backlogs, setting priorities for screening, and applying modern technologies to overcome potential obstacles. Many novel approaches that were developed and applied during the COVID-19 pandemic, such as the risk-stratified approach that takes into account personal CRC risk and the local epidemic status, as well as new digital technologies, are expected to play important roles in CRC screening in the future. AbstractColorectal cancer(CRC) is one of the most prevalent malignancies in the Asia-Pacific region, and many countries in this region have launched population CRC service screening. In this study, CRC screening key indicators, including the FIT(fecal immunochemical test) screening rate (or participation rate) and the rate of undergoing colonoscopy after positive FIT in 2019 and 2020, were surveyed in individual countries in the Asia-Pacific region. The impact of the pandemic on the effectiveness of CRC screening was simulated given different screening rates and colonoscopy rates and assuming the pandemic would persist or remain poorly controlled for a long period of time, using the empirical data from the Taiwanese program and the CRC natural history model. During the COVID-19 pandemic, most of the programs in this region were affected, but to different extents, which was largely influenced by the severity of the local pandemic. Most of the programs continued screening services in 2020, although a temporary pause occurred in some countries. The modeling study revealed that prolonged pauses of screening led to 6% lower effectiveness in reducing CRC mortality. Screening organizers should coordinate with health authorities to elaborate on addressing screening backlogs, setting priorities for screening, and applying modern technologies to overcome potential obstacles. Many novel approaches that were developed and applied during the COVID-19 pandemic, such as the risk-stratified approach that takes into account personal CRC risk and the local epidemic status, as well as new digital technologies, are expected to play important roles in CRC screening in the future. Colorectal cancer(CRC) is one of the most prevalent malignancies in the Asia-Pacific region, and many countries in this region have launched population CRC service screening. In this study, CRC screening key indicators, including the FIT(fecal immunochemical test) screening rate (or participation rate) and the rate of undergoing colonoscopy after positive FIT in 2019 and 2020, were surveyed in individual countries in the Asia-Pacific region. The impact of the pandemic on the effectiveness of CRC screening was simulated given different screening rates and colonoscopy rates and assuming the pandemic would persist or remain poorly controlled for a long period of time, using the empirical data from the Taiwanese program and the CRC natural history model. During the COVID-19 pandemic, most of the programs in this region were affected, but to different extents, which was largely influenced by the severity of the local pandemic. Most of the programs continued screening services in 2020, although a temporary pause occurred in some countries. The modeling study revealed that prolonged pauses of screening led to 6% lower effectiveness in reducing CRC mortality. Screening organizers should coordinate with health authorities to elaborate on addressing screening backlogs, setting priorities for screening, and applying modern technologies to overcome potential obstacles. Many novel approaches that were developed and applied during the COVID-19 pandemic, such as the risk-stratified approach that takes into account personal CRC risk and the local epidemic status, as well as new digital technologies, are expected to play important roles in CRC screening in the future. •More than half of global colorectal cancers (CRCs) currently occur in the Asia-Pacific region.•The COVID-19 pandemic has significantly affected CRC screening service globally, but less so in the Asia-Pacific region.•Risk-stratified approach and modern technologies are the key to mitigating the impact of pandemics on CRC screening. |
| ArticleNumber | 106622 |
| Author | Chiu, Han-Mo Chen, Sam Li-Sheng Hsu, Chen-Yang Chen, Hsiu-Hsi Jen, Grace Hsiao-Hsuan Hsu, Weng-Feng Su, Chiu-Wen |
| Author_xml | – sequence: 1 givenname: Han-Mo surname: Chiu fullname: Chiu, Han-Mo email: hanmochiu@ntu.edu.tw organization: Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan – sequence: 2 givenname: Chiu-Wen surname: Su fullname: Su, Chiu-Wen organization: Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan – sequence: 3 givenname: Weng-Feng surname: Hsu fullname: Hsu, Weng-Feng organization: Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan – sequence: 4 givenname: Grace Hsiao-Hsuan surname: Jen fullname: Jen, Grace Hsiao-Hsuan organization: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan – sequence: 5 givenname: Chen-Yang surname: Hsu fullname: Hsu, Chen-Yang organization: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan – sequence: 6 givenname: Sam Li-Sheng surname: Chen fullname: Chen, Sam Li-Sheng organization: School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan – sequence: 7 givenname: Hsiu-Hsi surname: Chen fullname: Chen, Hsiu-Hsi organization: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34044024$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkltvEzEQhS1URNPAL0BCfuRlg8fr7GZBVKrCrVJRkLi8Wo53Np2wsRd7Eyn8Af423qblUgn6ZMme7xz5nDlhR847ZOwxiAkIKJ6tJ_tug_VECgnppiikvMdGIKoiE7IQR2wkRAVZqfLpMTuJcS0EQCHUA3acK6GUkGrEfrynnlamJ7fi_SVy2nTG9tw3fL74cv4qg4p7x61vfUDbm5Zb4ywGHm1AdIl6zhdhZRx9x5pHDDuy-PuRdxhil0DaYeRN8Jsrk7NIJvtgLDVkecAVefeQ3W9MG_HR9Tlmn9-8_jR_l10s3p7Pzy4yW-Syz5Q0WGO5LGWpjK0w_RZA1kIas7RWIshZVZkKpjCrG2yKZd00ZV1ILOsZNCDzMTs96HbbZQrPouuDaXUXaGPCXntD-u8XR5d65Xd6plQO5TQJPL0WCP7bFmOvNxQttq1x6LdRy2muCshnMIw--dPrl8lN-mmgOgzY4GMM2GhLferCD9bUahB6aFqv9VXTemhaH5pObH6LvZH_P_XyQGHKeEcYdLSEqdGahn517ekO_vQWb1tyZE37FfcY134bXKpPg45SC_1x2MBhASUIIUXKZcxe_FvgTvufYevuiA |
| CitedBy_id | crossref_primary_10_3389_fonc_2022_955377 crossref_primary_10_1016_j_bpg_2025_102047 crossref_primary_10_1186_s12913_023_10327_8 crossref_primary_10_1371_journal_pone_0270223 crossref_primary_10_1136_gutjnl_2022_328559 crossref_primary_10_1136_gutjnl_2022_327377 crossref_primary_10_1007_s40944_022_00628_x crossref_primary_10_1016_j_canep_2022_102174 crossref_primary_10_1136_bmjgast_2021_000826 crossref_primary_10_1002_aid2_13437 crossref_primary_10_5339_qmj_2025_85 crossref_primary_10_1002_ijc_35371 |
| Cites_doi | 10.1136/bmjopen-2020-046667 10.1002/ijc.24458 10.1002/cncr.29462 10.1016/j.annonc.2020.05.009 10.14309/01.ajg.0000703320.30592.7b 10.4143/crt.2010.42.4.191 10.1001/jama.2017.3634 10.1136/gutjnl-2020-322179 10.1258/096914107782912022 10.1007/s11894-019-0703-8 10.1053/j.gastro.2014.06.008 10.1158/1055-9965.EPI-17-0387 10.1136/gutjnl-2020-322545 10.1016/j.cgh.2018.10.041 10.1186/1471-2407-8-104 10.1136/gutjnl-2014-309086 10.1186/1471-2407-6-136 10.1016/S2589-7500(20)30194-1 10.1136/gutjnl-2015-310256 10.1055/a-1272-3788 10.2196/21409 10.1055/a-1159-0644 10.1038/s41591-020-1011-4 10.1093/ije/14.1.32 10.1136/gutjnl-2014-307508 10.1053/j.gastro.2019.10.007 10.2196/11114 10.1053/j.gastro.2018.07.017 10.1001/jamainternmed.2018.3629 10.1038/ajg.2015.240 10.1371/journal.pone.0248679 10.1053/j.gastro.2015.11.042 |
| ContentType | Journal Article |
| Copyright | 2021 The Author(s) The Author(s) Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. 2021 The Author(s) 2021 |
| Copyright_xml | – notice: 2021 The Author(s) – notice: The Author(s) – notice: Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. – notice: 2021 The Author(s) 2021 |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1016/j.ypmed.2021.106622 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1096-0260 |
| EndPage | 106622 |
| ExternalDocumentID | PMC8443175 34044024 10_1016_j_ypmed_2021_106622 S0091743521002061 1_s2_0_S0091743521002061 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Asia |
| GeographicLocations_xml | – name: Asia |
| GroupedDBID | --- --K --M -ET .1- .55 .FO .GJ .~1 0R~ 123 1B1 1CY 1P~ 1RT 1~. 1~5 29O 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABDPE ABFNM ABFRF ABJNI ABMAC ABMZM ABXDB ACDAQ ACGFO ACGFS ACIEU ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO ADVLN ADXHL AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AHHHB AI2 AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DM4 DU5 EBS EFBJH EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEA HMK HMO HVGLF HZ~ IH2 IHE J1W KOM LG5 LZ2 M29 M41 MO0 N4W N9A O-L O9- OAUVE OD~ OHT OO0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SES SEW SPCBC SSH SSZ T5K TWZ UNMZH VJK WUQ X7M XPP Z5R ZGI ZMT ZU3 ~G- ~HD ~KM 0SF AACTN AFCTW AFKWA AJOXV AMFUW NCXOZ PKN RIG 6I. AAFTH AAIAV ABLVK ABYKQ AHPSJ AJBFU G8K LCYCR 9DU AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c632t-42aede7b7274ac9e109112d02aabcc2e12899a91518dfef6bdff7d62e7d81f123 |
| ISICitedReferencesCount | 17 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000668494400017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0091-7435 1096-0260 |
| IngestDate | Tue Sep 30 16:37:38 EDT 2025 Wed Oct 01 14:00:54 EDT 2025 Wed Feb 19 02:26:15 EST 2025 Tue Nov 18 22:28:23 EST 2025 Sat Nov 29 07:25:40 EST 2025 Fri Feb 23 02:46:20 EST 2024 Tue Feb 25 20:09:54 EST 2025 Tue Oct 14 19:40:33 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | FIT CRC FHbC Fecal hemoglobin concentration Fecal immunochemical test Colorectal cancer |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c632t-42aede7b7274ac9e109112d02aabcc2e12899a91518dfef6bdff7d62e7d81f123 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC8443175 |
| PMID | 34044024 |
| PQID | 2534613815 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8443175 proquest_miscellaneous_2534613815 pubmed_primary_34044024 crossref_citationtrail_10_1016_j_ypmed_2021_106622 crossref_primary_10_1016_j_ypmed_2021_106622 elsevier_sciencedirect_doi_10_1016_j_ypmed_2021_106622 elsevier_clinicalkeyesjournals_1_s2_0_S0091743521002061 elsevier_clinicalkey_doi_10_1016_j_ypmed_2021_106622 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-10-01 |
| PublicationDateYYYYMMDD | 2021-10-01 |
| PublicationDate_xml | – month: 10 year: 2021 text: 2021-10-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Preventive medicine |
| PublicationTitleAlternate | Prev Med |
| PublicationYear | 2021 |
| Publisher | Elsevier Inc The Author(s). Published by Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc – name: The Author(s). Published by Elsevier Inc |
| References | Chiu, Chuang, Chen (bb0060) 2017; 66 Rose (bb0155) 1985; 14 Bowel scope screening to stop in England (bb0025) Myint, Hilda, Lee, Roh, Connoly (bb0005) 2020; 115 Coronado, Petrik, Vollmer (bb0075) 2018; 178 Eisinger, Cals, Calazel-Benque (bb0090) 2008; 8 Bowel screening (bb0030) Global Cancer Observatory: Cancer Today (bb0110) Gupta, Coronado, Argenbright (bb0115) 2020; 70 Delayed Cancer Screenings—A Second Look (bb0085) Sarkeala, Farkkila, Anttila (bb0175) 2021; 11 Tai, Chi, Chiu (bb0195) 2021; 5 McCall (bb0020) 2020; 2 Levin, Corley, Jensen (bb0130) 2018; 155 Coronavirus disease 2019(COVID-19) (bb0080) Auge, Pellise, Escudero (bb0010) 2014; 147 Budd, Miller, Manning (bb0035) 2020; 26 Zorzi, Hassan, Capodaglio (bb0215) 2020; 52 Sarakarn, Promthet, Vatanasapt (bb0170) 2017; 18 Lantinga, Theunissen, Ter Borg (bb0120) 2021; 53 Giorgi Rossi, Vicentini, Sacchettini (bb0105) 2015; 110 Onyoh, Hsu, Chang (bb0140) 2019; 21 Wu, Wang, Yen (bb0205) 2006; 6 van Rossum, van Rijn, van Oijen (bb0200) 2009; 125 Rabeneck, Chiu, Senore (bb0145) 2020; 158 Rutter, Brookes, Lee (bb0160) 2021; 70 Schreuders, Ruco, Rabeneck (bb0180) 2015; 64 El Bizri, El Sheikh, Lee (bb0095) 2021; 16 Shim, Kim, Han (bb0185) 2010; 42 Li, Zhao, Ma (bb0135) 2018; 97 Azulay, Valinsky, Hershkowitz (bb0015) 2019; 7 Chiu, Chen, Yen (bb0050) 2015; 121 Chiu, Jen, Wang (bb0065) 2021 Zorzi, Fedeli, Schievano (bb0210) 2015; 64 Chen, Liao, Chang (bb0040) 2007; 14 Sud, Jones, Broggio (bb0190) 2020; 31 Eligibility of Colorectal Cancer Screening Programme updated (bb0100) Chen, Hsu, Yen (bb0045) 2018; 27 Lee, Fann, Chiang (bb0125) 2019; 17 Review of the impact of COVID-19 on medical services and procedures in Australia utilising MBS data: skin, breast and colorectal cancers, and telehealth services (bb0150) Chiu, Ching, Wu (bb0055) 2016; 150 Corley, Jensen, Quinn (bb0070) 2017; 317 Saito (bb0165) 2006; 13 Tai (10.1016/j.ypmed.2021.106622_bb0195) 2021; 5 Zorzi (10.1016/j.ypmed.2021.106622_bb0210) 2015; 64 Lantinga (10.1016/j.ypmed.2021.106622_bb0120) 2021; 53 Sarkeala (10.1016/j.ypmed.2021.106622_bb0175) 2021; 11 Chiu (10.1016/j.ypmed.2021.106622_bb0060) 2017; 66 Bowel scope screening to stop in England (10.1016/j.ypmed.2021.106622_bb0025) Chiu (10.1016/j.ypmed.2021.106622_bb0055) 2016; 150 Myint (10.1016/j.ypmed.2021.106622_bb0005) 2020; 115 Rose (10.1016/j.ypmed.2021.106622_bb0155) 1985; 14 Sarakarn (10.1016/j.ypmed.2021.106622_bb0170) 2017; 18 Azulay (10.1016/j.ypmed.2021.106622_bb0015) 2019; 7 Levin (10.1016/j.ypmed.2021.106622_bb0130) 2018; 155 Eligibility of Colorectal Cancer Screening Programme updated (10.1016/j.ypmed.2021.106622_bb0100) Onyoh (10.1016/j.ypmed.2021.106622_bb0140) 2019; 21 Global Cancer Observatory: Cancer Today (10.1016/j.ypmed.2021.106622_bb0110) Auge (10.1016/j.ypmed.2021.106622_bb0010) 2014; 147 Zorzi (10.1016/j.ypmed.2021.106622_bb0215) 2020; 52 Chen (10.1016/j.ypmed.2021.106622_bb0045) 2018; 27 Rabeneck (10.1016/j.ypmed.2021.106622_bb0145) 2020; 158 Li (10.1016/j.ypmed.2021.106622_bb0135) 2018; 97 Saito (10.1016/j.ypmed.2021.106622_bb0165) 2006; 13 Sud (10.1016/j.ypmed.2021.106622_bb0190) 2020; 31 Bowel screening (10.1016/j.ypmed.2021.106622_bb0030) Chen (10.1016/j.ypmed.2021.106622_bb0040) 2007; 14 Shim (10.1016/j.ypmed.2021.106622_bb0185) 2010; 42 Chiu (10.1016/j.ypmed.2021.106622_bb0050) 2015; 121 Giorgi Rossi (10.1016/j.ypmed.2021.106622_bb0105) 2015; 110 Lee (10.1016/j.ypmed.2021.106622_bb0125) 2019; 17 Rutter (10.1016/j.ypmed.2021.106622_bb0160) 2021; 70 van Rossum (10.1016/j.ypmed.2021.106622_bb0200) 2009; 125 McCall (10.1016/j.ypmed.2021.106622_bb0020) 2020; 2 Review of the impact of COVID-19 on medical services and procedures in Australia utilising MBS data: skin, breast and colorectal cancers, and telehealth services (10.1016/j.ypmed.2021.106622_bb0150) Budd (10.1016/j.ypmed.2021.106622_bb0035) 2020; 26 Corley (10.1016/j.ypmed.2021.106622_bb0070) 2017; 317 El Bizri (10.1016/j.ypmed.2021.106622_bb0095) 2021; 16 Coronavirus disease 2019(COVID-19) (10.1016/j.ypmed.2021.106622_bb0080) Delayed Cancer Screenings—A Second Look (10.1016/j.ypmed.2021.106622_bb0085) Eisinger (10.1016/j.ypmed.2021.106622_bb0090) 2008; 8 Gupta (10.1016/j.ypmed.2021.106622_bb0115) 2020; 70 Coronado (10.1016/j.ypmed.2021.106622_bb0075) 2018; 178 Schreuders (10.1016/j.ypmed.2021.106622_bb0180) 2015; 64 Wu (10.1016/j.ypmed.2021.106622_bb0205) 2006; 6 Chiu (10.1016/j.ypmed.2021.106622_bb0065) 2021 |
| References_xml | – volume: 2 start-page: E456 year: 2020 end-page: E457 ident: bb0020 article-title: Could telemedicine solve the cancer backlog? publication-title: Lancet Digital Health – volume: 11 year: 2021 ident: bb0175 article-title: Piloting gender-oriented colorectal cancer screening with a faecal immunochemical test: population-based registry study from Finland publication-title: BMJ Open – ident: bb0030 – volume: 158 start-page: 447 year: 2020 end-page: 452 ident: bb0145 article-title: International perspective on the burden of colorectal Cancer and public health effects publication-title: Gastroenterology – volume: 178 start-page: 1174 year: 2018 end-page: 1181 ident: bb0075 article-title: Effectiveness of a mailed colorectal Cancer screening outreach program in community health clinics: the STOP CRC cluster randomized clinical trial publication-title: JAMA Intern. Med. – ident: bb0100 – volume: 110 start-page: 1359 year: 2015 end-page: 1366 ident: bb0105 article-title: Impact of screening program on incidence of colorectal Cancer: a cohort study in Italy publication-title: Am. J. Gastroenterol. – volume: 18 start-page: 2883 year: 2017 end-page: 2889 ident: bb0170 article-title: Preliminary results: colorectal Cancer screening using fecal immunochemical test (FIT) in a Thai population aged 45-74 years: a population-based randomized controlled trial publication-title: Asian Pac. J. Cancer Prev. – volume: 8 start-page: 104 year: 2008 ident: bb0090 article-title: Impact of organised programs on colorectal cancer screening publication-title: BMC Cancer – year: 2021 ident: bb0065 article-title: Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers publication-title: Gut – volume: 64 start-page: 1637 year: 2015 end-page: 1649 ident: bb0180 article-title: Colorectal cancer screening: a global overview of existing programmes publication-title: Gut – volume: 70 start-page: 283 year: 2020 end-page: 298 ident: bb0115 article-title: Mailed fecal immunochemical test outreach for colorectal cancer screening: summary of a Centers for Disease Control and Prevention-sponsored summit publication-title: CA Cancer J. Clin. – volume: 21 start-page: 36 year: 2019 ident: bb0140 article-title: The rise of colorectal Cancer in Asia: epidemiology, screening, and management publication-title: Curr. Gastroenterol Rep. – volume: 147 start-page: 628 year: 2014 end-page: 636 ident: bb0010 article-title: Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program publication-title: Gastroenterology – volume: 64 start-page: 784 year: 2015 end-page: 790 ident: bb0210 article-title: Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test publication-title: Gut – ident: bb0150 – volume: 70 start-page: 537 year: 2021 end-page: 543 ident: bb0160 article-title: Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a National Endoscopy Database Analysis publication-title: Gut – volume: 150 start-page: 617 year: 2016 end-page: 625 ident: bb0055 article-title: A risk-scoring system combined with a fecal immunochemical test is effective in screening high-risk subjects for early colonoscopy to detect advanced colorectal neoplasms publication-title: Gastroenterology – volume: 16 year: 2021 ident: bb0095 article-title: Mobile health technologies supporting colonoscopy preparation: a systematic review and meta-analysis of randomized controlled trials publication-title: PLoS One – volume: 66 start-page: 293 year: 2017 end-page: 300 ident: bb0060 article-title: Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program publication-title: Gut – ident: bb0080 – volume: 155 start-page: 1383 year: 2018 end-page: 1391 ident: bb0130 article-title: Effects of organized colorectal Cancer screening on Cancer incidence and mortality in a large community-based population publication-title: Gastroenterology – volume: 42 start-page: 191 year: 2010 end-page: 198 ident: bb0185 article-title: Results of colorectal cancer screening of the national cancer screening program in Korea, 2008 publication-title: Cancer Res. Treat. – volume: 5 year: 2021 ident: bb0195 article-title: The effect of a name-based mask rationing plan in Taiwan on public anxiety regarding a mask shortage during the COVID-19 pandemic: observational study publication-title: JMIR Form Res – ident: bb0025 – volume: 125 start-page: 746 year: 2009 end-page: 750 ident: bb0200 article-title: False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening publication-title: Int. J. Cancer – volume: 13 start-page: S6 year: 2006 end-page: S7 ident: bb0165 article-title: Colorectal cancer screening using immunochemical faecal occult blood testing in Japan publication-title: J. Med. Screen. – volume: 52 start-page: 871 year: 2020 end-page: 876 ident: bb0215 article-title: Colonoscopy later than 270 days in a fecal immunochemical test-based population screening program is associated with higher prevalence of colorectal cancer publication-title: Endoscopy – volume: 53 start-page: 166 year: 2021 end-page: 170 ident: bb0120 article-title: Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database publication-title: Endoscopy – volume: 121 start-page: 3221 year: 2015 end-page: 3229 ident: bb0050 article-title: Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program publication-title: Cancer – volume: 14 start-page: 191 year: 2007 end-page: 199 ident: bb0040 article-title: Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16) publication-title: J. Med. Screen. – volume: 27 start-page: 704 year: 2018 end-page: 709 ident: bb0045 article-title: Demand for colonoscopy in colorectal Cancer screening using a quantitative fecal immunochemical test and age/sex-specific thresholds for test positivity publication-title: Cancer Epidemiol. Biomark. Prev. – volume: 97 year: 2018 ident: bb0135 article-title: Predicting the risk for colorectal cancer with personal characteristics and fecal immunochemical test publication-title: Medicine (Baltimore) – volume: 7 year: 2019 ident: bb0015 article-title: Repeated automated mobile text messaging reminders for follow-up of positive fecal occult blood tests: randomized controlled trial publication-title: JMIR Mhealth Uhealth – volume: 26 start-page: 1183 year: 2020 end-page: 1192 ident: bb0035 article-title: Digital technologies in the public-health response to COVID-19 publication-title: Nat. Med. – ident: bb0110 – volume: 317 start-page: 1631 year: 2017 end-page: 1641 ident: bb0070 article-title: Association between time to colonoscopy after a positive fecal test result and risk of colorectal Cancer and Cancer stage at diagnosis publication-title: JAMA – ident: bb0085 – volume: 115 start-page: S154 year: 2020 end-page: S155 ident: bb0005 article-title: Impact of the COVID-19 pandemic on colorectal Cancer screening rates and modalities in a large integrated health system publication-title: Am. J. Gastroenterol. – volume: 14 start-page: 32 year: 1985 end-page: 38 ident: bb0155 article-title: Sick individuals and sick populations publication-title: Int. J. Epidemiol. – volume: 31 start-page: 1065 year: 2020 end-page: 1074 ident: bb0190 article-title: Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic publication-title: Ann. Oncol. – volume: 6 start-page: 136 year: 2006 ident: bb0205 article-title: Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries publication-title: BMC Cancer – volume: 17 start-page: 1332 year: 2019 end-page: 1340 ident: bb0125 article-title: Time to colonoscopy and risk of colorectal Cancer in patients with positive results from fecal immunochemical tests publication-title: Clin. Gastroenterol. Hepatol. – volume: 11 year: 2021 ident: 10.1016/j.ypmed.2021.106622_bb0175 article-title: Piloting gender-oriented colorectal cancer screening with a faecal immunochemical test: population-based registry study from Finland publication-title: BMJ Open doi: 10.1136/bmjopen-2020-046667 – volume: 125 start-page: 746 year: 2009 ident: 10.1016/j.ypmed.2021.106622_bb0200 article-title: False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening publication-title: Int. J. Cancer doi: 10.1002/ijc.24458 – volume: 13 start-page: S6 issue: Suppl. 1 year: 2006 ident: 10.1016/j.ypmed.2021.106622_bb0165 article-title: Colorectal cancer screening using immunochemical faecal occult blood testing in Japan publication-title: J. Med. Screen. – volume: 121 start-page: 3221 year: 2015 ident: 10.1016/j.ypmed.2021.106622_bb0050 article-title: Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program publication-title: Cancer doi: 10.1002/cncr.29462 – volume: 31 start-page: 1065 year: 2020 ident: 10.1016/j.ypmed.2021.106622_bb0190 article-title: Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic publication-title: Ann. Oncol. doi: 10.1016/j.annonc.2020.05.009 – volume: 18 start-page: 2883 year: 2017 ident: 10.1016/j.ypmed.2021.106622_bb0170 article-title: Preliminary results: colorectal Cancer screening using fecal immunochemical test (FIT) in a Thai population aged 45-74 years: a population-based randomized controlled trial publication-title: Asian Pac. J. Cancer Prev. – volume: 115 start-page: S154 year: 2020 ident: 10.1016/j.ypmed.2021.106622_bb0005 article-title: Impact of the COVID-19 pandemic on colorectal Cancer screening rates and modalities in a large integrated health system publication-title: Am. J. Gastroenterol. doi: 10.14309/01.ajg.0000703320.30592.7b – ident: 10.1016/j.ypmed.2021.106622_bb0150 – volume: 42 start-page: 191 year: 2010 ident: 10.1016/j.ypmed.2021.106622_bb0185 article-title: Results of colorectal cancer screening of the national cancer screening program in Korea, 2008 publication-title: Cancer Res. Treat. doi: 10.4143/crt.2010.42.4.191 – volume: 317 start-page: 1631 year: 2017 ident: 10.1016/j.ypmed.2021.106622_bb0070 article-title: Association between time to colonoscopy after a positive fecal test result and risk of colorectal Cancer and Cancer stage at diagnosis publication-title: JAMA doi: 10.1001/jama.2017.3634 – ident: 10.1016/j.ypmed.2021.106622_bb0110 – volume: 70 start-page: 537 year: 2021 ident: 10.1016/j.ypmed.2021.106622_bb0160 article-title: Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a National Endoscopy Database Analysis publication-title: Gut doi: 10.1136/gutjnl-2020-322179 – volume: 14 start-page: 191 year: 2007 ident: 10.1016/j.ypmed.2021.106622_bb0040 article-title: Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16) publication-title: J. Med. Screen. doi: 10.1258/096914107782912022 – volume: 97 year: 2018 ident: 10.1016/j.ypmed.2021.106622_bb0135 article-title: Predicting the risk for colorectal cancer with personal characteristics and fecal immunochemical test publication-title: Medicine (Baltimore) – volume: 21 start-page: 36 year: 2019 ident: 10.1016/j.ypmed.2021.106622_bb0140 article-title: The rise of colorectal Cancer in Asia: epidemiology, screening, and management publication-title: Curr. Gastroenterol Rep. doi: 10.1007/s11894-019-0703-8 – volume: 147 start-page: 628 year: 2014 ident: 10.1016/j.ypmed.2021.106622_bb0010 article-title: Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program publication-title: Gastroenterology doi: 10.1053/j.gastro.2014.06.008 – volume: 27 start-page: 704 year: 2018 ident: 10.1016/j.ypmed.2021.106622_bb0045 article-title: Demand for colonoscopy in colorectal Cancer screening using a quantitative fecal immunochemical test and age/sex-specific thresholds for test positivity publication-title: Cancer Epidemiol. Biomark. Prev. doi: 10.1158/1055-9965.EPI-17-0387 – ident: 10.1016/j.ypmed.2021.106622_bb0030 – year: 2021 ident: 10.1016/j.ypmed.2021.106622_bb0065 article-title: Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers publication-title: Gut doi: 10.1136/gutjnl-2020-322545 – volume: 17 start-page: 1332 year: 2019 ident: 10.1016/j.ypmed.2021.106622_bb0125 article-title: Time to colonoscopy and risk of colorectal Cancer in patients with positive results from fecal immunochemical tests publication-title: Clin. Gastroenterol. Hepatol. doi: 10.1016/j.cgh.2018.10.041 – volume: 8 start-page: 104 year: 2008 ident: 10.1016/j.ypmed.2021.106622_bb0090 article-title: Impact of organised programs on colorectal cancer screening publication-title: BMC Cancer doi: 10.1186/1471-2407-8-104 – volume: 64 start-page: 1637 year: 2015 ident: 10.1016/j.ypmed.2021.106622_bb0180 article-title: Colorectal cancer screening: a global overview of existing programmes publication-title: Gut doi: 10.1136/gutjnl-2014-309086 – volume: 6 start-page: 136 year: 2006 ident: 10.1016/j.ypmed.2021.106622_bb0205 article-title: Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries publication-title: BMC Cancer doi: 10.1186/1471-2407-6-136 – volume: 2 start-page: E456 year: 2020 ident: 10.1016/j.ypmed.2021.106622_bb0020 article-title: Could telemedicine solve the cancer backlog? publication-title: Lancet Digital Health doi: 10.1016/S2589-7500(20)30194-1 – volume: 66 start-page: 293 year: 2017 ident: 10.1016/j.ypmed.2021.106622_bb0060 article-title: Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program publication-title: Gut doi: 10.1136/gutjnl-2015-310256 – volume: 53 start-page: 166 year: 2021 ident: 10.1016/j.ypmed.2021.106622_bb0120 article-title: Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database publication-title: Endoscopy doi: 10.1055/a-1272-3788 – volume: 70 start-page: 283 year: 2020 ident: 10.1016/j.ypmed.2021.106622_bb0115 article-title: Mailed fecal immunochemical test outreach for colorectal cancer screening: summary of a Centers for Disease Control and Prevention-sponsored summit publication-title: CA Cancer J. Clin. – volume: 5 year: 2021 ident: 10.1016/j.ypmed.2021.106622_bb0195 article-title: The effect of a name-based mask rationing plan in Taiwan on public anxiety regarding a mask shortage during the COVID-19 pandemic: observational study publication-title: JMIR Form Res doi: 10.2196/21409 – volume: 52 start-page: 871 year: 2020 ident: 10.1016/j.ypmed.2021.106622_bb0215 article-title: Colonoscopy later than 270 days in a fecal immunochemical test-based population screening program is associated with higher prevalence of colorectal cancer publication-title: Endoscopy doi: 10.1055/a-1159-0644 – volume: 26 start-page: 1183 year: 2020 ident: 10.1016/j.ypmed.2021.106622_bb0035 article-title: Digital technologies in the public-health response to COVID-19 publication-title: Nat. Med. doi: 10.1038/s41591-020-1011-4 – volume: 14 start-page: 32 year: 1985 ident: 10.1016/j.ypmed.2021.106622_bb0155 article-title: Sick individuals and sick populations publication-title: Int. J. Epidemiol. doi: 10.1093/ije/14.1.32 – volume: 64 start-page: 784 year: 2015 ident: 10.1016/j.ypmed.2021.106622_bb0210 article-title: Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test publication-title: Gut doi: 10.1136/gutjnl-2014-307508 – volume: 158 start-page: 447 year: 2020 ident: 10.1016/j.ypmed.2021.106622_bb0145 article-title: International perspective on the burden of colorectal Cancer and public health effects publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.10.007 – volume: 7 year: 2019 ident: 10.1016/j.ypmed.2021.106622_bb0015 article-title: Repeated automated mobile text messaging reminders for follow-up of positive fecal occult blood tests: randomized controlled trial publication-title: JMIR Mhealth Uhealth doi: 10.2196/11114 – volume: 155 start-page: 1383 year: 2018 ident: 10.1016/j.ypmed.2021.106622_bb0130 article-title: Effects of organized colorectal Cancer screening on Cancer incidence and mortality in a large community-based population publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.07.017 – volume: 178 start-page: 1174 year: 2018 ident: 10.1016/j.ypmed.2021.106622_bb0075 article-title: Effectiveness of a mailed colorectal Cancer screening outreach program in community health clinics: the STOP CRC cluster randomized clinical trial publication-title: JAMA Intern. Med. doi: 10.1001/jamainternmed.2018.3629 – ident: 10.1016/j.ypmed.2021.106622_bb0085 – ident: 10.1016/j.ypmed.2021.106622_bb0080 – volume: 110 start-page: 1359 year: 2015 ident: 10.1016/j.ypmed.2021.106622_bb0105 article-title: Impact of screening program on incidence of colorectal Cancer: a cohort study in Italy publication-title: Am. J. Gastroenterol. doi: 10.1038/ajg.2015.240 – volume: 16 year: 2021 ident: 10.1016/j.ypmed.2021.106622_bb0095 article-title: Mobile health technologies supporting colonoscopy preparation: a systematic review and meta-analysis of randomized controlled trials publication-title: PLoS One doi: 10.1371/journal.pone.0248679 – ident: 10.1016/j.ypmed.2021.106622_bb0100 – volume: 150 start-page: 617 year: 2016 ident: 10.1016/j.ypmed.2021.106622_bb0055 article-title: A risk-scoring system combined with a fecal immunochemical test is effective in screening high-risk subjects for early colonoscopy to detect advanced colorectal neoplasms publication-title: Gastroenterology doi: 10.1053/j.gastro.2015.11.042 – ident: 10.1016/j.ypmed.2021.106622_bb0025 |
| SSID | ssj0011604 |
| Score | 2.4458187 |
| Snippet | Colorectal cancer(CRC) is one of the most prevalent malignancies in the Asia-Pacific region, and many countries in this region have launched population CRC... AbstractColorectal cancer(CRC) is one of the most prevalent malignancies in the Asia-Pacific region, and many countries in this region have launched population... |
| SourceID | pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 106622 |
| SubjectTerms | Asia Colonoscopy Colorectal Neoplasms - diagnosis Colorectal Neoplasms - epidemiology COVID-19 Early Detection of Cancer Humans Internal Medicine Mass Screening Occult Blood Pandemics SARS-CoV-2 |
| Title | Mitigating the impact of COVID-19 on colorectal cancer screening: Organized service screening perspectives from the Asia-Pacific region |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0091743521002061 https://www.clinicalkey.es/playcontent/1-s2.0-S0091743521002061 https://dx.doi.org/10.1016/j.ypmed.2021.106622 https://www.ncbi.nlm.nih.gov/pubmed/34044024 https://www.proquest.com/docview/2534613815 https://pubmed.ncbi.nlm.nih.gov/PMC8443175 |
| Volume | 151 |
| WOSCitedRecordID | wos000668494400017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1096-0260 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0011604 issn: 0091-7435 databaseCode: AIEXJ dateStart: 20141101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbKhhDShGDcymUyEm_DU-3mZt6mMuiQOpAY0DfLSZwt05RUTVttv4An_jPHsZ20K4yLxEtUOfEl-b7ax_Y5nxF6mQQczO4sJjxWPvGoUiSKfUpgrGRJ4qdawr0-bCI8OorGY_6x0_nuYmEW52FRRBcXfPJfoYY0AFuHzv4F3E2hkAC_AXS4Auxw_SPgR7mRzbBhUG0Y5ODDl8M3hHK9P6C1qnVfp9VBNO7TXeg-YEprw59thCYYo5XpS9rbWujYhWdWS9EpVS6J9fDb1ac9WLit3euUohZqbTd_cJrP6wFQFmRUtptUxhkgn5OvbbTasKqTIeWEwEc_afx_TOf5biqhqUNoSkngUUt8u6bBaOMdZxfaXLDNii8oWIOUgMHjr3TeRq52bSAwaxJne5cTeKs9XQekBYGJgb6isP1Jl6wLZlqPtqcn05ss9Dl0kpv7hwfj9822FA16RtbbtsTJWNUOg2tV_crUWZ_KXPXIXTJxju-iO3ZugvcNp-6hjiq20a2RxWsbbZk1XmxC1-6jby3VMHAAG6rhMsOOargscEs1bKiGGy69xg3RsCVaexMvEw1rotWVLBMNG6I9QJ_fHhwPhsQe7EGSoM9mxGNSpSqMwXb2ZMKVFqelLO0xKeMkYYrqVQDJAdsozVQWxGmWhWnAVJhGNANb6yHaKMpCPUaYx9KXHoNyYWCJueJxJGHSEEqf-SxQYRcxh4FIrOq9PnzlXDj3xjNRAyc0cMIA10WvmkwTI_py_eOeA1e4eGYYgQVw8fps4c-yqcp2JpWgomKiJ9b42UVBk9MaysYA_n2VLxz3BAwjem9QFqqcV4L5fQ8s-4j6XfTIcLF59b6nz6VnHjR4haXNA1qifvVOkZ_WUvWRV09QnvzbF3qKbre9wzO0MZvO1XN0M1nM8mq6g26E42jH_kV_ACQPDhE |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mitigating+the+impact+of+COVID-19+on+colorectal+cancer+screening%3A+Organized+service+screening+perspectives+from+the+Asia-Pacific+region&rft.jtitle=Preventive+medicine&rft.au=Chiu%2C+Han-Mo&rft.au=Su%2C+Chiu-Wen&rft.au=Hsu%2C+Weng-Feng&rft.au=Jen%2C+Grace+Hsiao-Hsuan&rft.date=2021-10-01&rft.pub=Elsevier+Inc&rft.issn=0091-7435&rft.volume=151&rft_id=info:doi/10.1016%2Fj.ypmed.2021.106622&rft.externalDocID=S0091743521002061 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00917435%2FS0091743521X00096%2Fcov150h.gif |